Abstract:Background: Lines of evidence have suggested that the brain-derived neurotrophic factor (BDNF) gene may be involved in the pathogenesis of schizophrenia. Two common functional polymorphisms C-270T and Val66Met within the BDNF gene were first reported by Kunugi et al. [Kunugi, H., Nanko, S., Hirasawa, H., Kato, N., Nabika, T., Kobayashi, S., 2003. Brain-derived neurotrophic factor gene and schizophrenia: polymorphism screening and association analysis. Schizophr. Res. 62, 281-283.] and pls expand this too: Hong et al. (2003) to be significantly associated with schizophrenia. However, subsequently several studies obtained conflicting results.Methods: We compared the allele/genotype frequencies of the C-270T and Va166Met polymorphisms and the haplotype frequencies at the two polymorphisms in a moderate independent patient-control sample from the Han Chinese population. Two systematic meta-analyses were performed to assess the collective evidence for association across studies for each of the two polymorphisms.Results: No statistically significant differences were found in allele or genotype or haplotype frequencies between patient and normal control subjects for either of the two polymorphisms. On the other hand, the meta-analysis of all published population-based association studies showed statistically significant evidence for heterogeneity among each of the two polymorphisms. Stratification of the studies by ethnicity of the samples yielded no significant evidence for an association with the polymorphisms in the Caucasian population (for C-270T polymorphism: pooled ORCaucasian=0.736, 95% CI=0.476-1.139, p=0.169; for Val66Met polymorphism: pooled 0RC:aucasim- 1.027, 95% CI=0.796-1.325, p=0.835), nor in the Asian population (for C-270T polymorphism: pooled ORAsian =0.445, 95% CI=0.144-1.373, p=0.159; for Val66Met polymorphism: pooled ORAsian=0.962, 95% CI=0.820-1.128, p=0.635).Conclusions: Our population-based study and meta-analysis demonstrate that the BDNF C-270T and Val66Met polymorphisms do not play major roles in the susceptibility to schizophrenia in either Caucasian or Asian populations. But we can not rule out the possibility that other polymorphisms with the BDNF gene are involved in the pathophysiology of schizophrenia. (c) 2006 Elsevier B.V All rights reserved.

the Association of BDNF Val66Met Gene Polymorphism and Family Function

Association Of Brain-Derived Neurotrophic Factor Genetic Val66met Polymorphism With Severity Of Depression, Efficacy Of Fluoxetine And Its Side Effects In Chinese Major Depressive Patients

Association of BDNF Val66Met polymorphism with both baseline HRQOL scores and improvement in HRQOL scores in Chinese major depressive patients treated with fluoxetine.

The BDNF Val66Met Polymorphism Interacts with Maternal Parenting Influencing Adolescent Depressive Symptoms: Evidence of Differential Susceptibility Model

Association Between Brain-Derived Neurotrophic Factor Val66Met Polymorphism and Methamphetamine Use Disorder: A Meta-Analysis

[Association Between Polymorphism of BDNF and Internalizing Disorders].

BDNF Val66Met polymorphism moderates negative symptom expression of bully victimization through resilience in Taiwanese youth

Evaluation of the Relationship Between BDNF Val66Met Gene Polymorphism and Attention Deficit Hyperactivity Disorder: A Meta-Analysis

Positive Association Between the Brain-Derived Neurotrophic Factor (bdnf) Gene and Bipolar Disorder in the Han Chinese Population

Cyberbullying Victimization and Psychopathological Symptoms among Adolescents Varied in BDNF Val66Met Polymorphism and Vagal Tone

Increased parasympathetic activity and ability to generate positive emotion: The influence of the BDNF Val66Met polymorphism on emotion flexibility

The Influence of BDNF Val66Met Polymorphism on Cognition, Cerebrospinal Fluid, and Neuroimaging Markers in Non-Demented Elderly.

Consequences of the rs6265 (Val66Met) polymorphism in the BDNF gene in selected mental disorders and sport

BDNF and stress/mood-related interactions on emotional disorder symptoms, executive functioning, and deliberate self-harm

Association Between Single Nucleotide Polymorphisms of Brain-Derived Neurotrophic Factor Gene and Attention Deficit Hyperactivity Disorder

The BDNF Val66Met polymorphism and health-related quality of life in youth with obesity

Met carriers of the BDNF Val66Met polymorphism show reduced Glx/NAA in the pregenual ACC in two independent cohorts

The brain-derived neurotrophic-factor (BDNF) val66met polymorphism is associated with geriatric depression: a meta-analysis.

Transcriptome profiling analysis of the mechanisms underlying the BDNF Val66Met polymorphism induced dysfunctions of the central nervous system

The BDNF gene Val66Met polymorphism as a modifier of psychiatric disorder susceptibility: progress and controversy

Brain-Derived Neurotrophic Factor Gene C-270t and Va166met Functional Polymorphisms and Risk of Schizophrenia: A Moderate-Scale Population-Based Study and Meta-Analysis